Abstract

Low-dose Pilocarpine Spray to Treat Xerostomia

Author(s): Zur Eyal

Issue: Mar/Apr 2020 - Volume 24, Number 2

Page(s): 104-108

Download in electronic PDF format for $75
  • Low-dose Pilocarpine Spray to Treat Xerostomia Page 1
  • Low-dose Pilocarpine Spray to Treat Xerostomia Page 2
  • Low-dose Pilocarpine Spray to Treat Xerostomia Page 3
  • Low-dose Pilocarpine Spray to Treat Xerostomia Page 4
  • Low-dose Pilocarpine Spray to Treat Xerostomia Page 5

Abstract

Although pilocarpine hydrochloride tablets are currently indicated for the treatment of xerostomia, their adverse effects are frequently reported. The development of a new, low-dose pilocarpine solution for topical oral-cavity use is needed. This article discusses a few clinical trials to formulate a topical low-dose solution of pilocarpine hydrochloride for the treatment of xerostomia and presents two low dose, stable formulations of pilocarpine topical spray that can improve the patient's quality of life with minimal adverse effects.

Related Keywords

  • xerostomia
  • dry mouth
  • Sjögren syndrome
  • head and neck radiotherapy
  • aging
  • pilocarpine hydrochloride
  • saliva secretion stimulant
  • cholinergic agonist
  • muscarinic activation
  • mucin
  • cevimeline
  • adverse effects
  • formulations
  • dosage forms
  • topical preparation
  • oral spray

Related Categories

  • DENTAL
  • EAR NOSE THROAT
  • FORMULATIONS
  • STABILITIES, COMPATIBILITIES
  • DOSAGE FORMS/DRUG CARRIERS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2020
Pg. 104-108
Low-dose Pilocarpine Spray to Treat Xerostomia
Author(s): Zur Eyal
Mar/Apr 2023
Pg. 149-151
Pilocarpine Hydrochloride 0.3% w/v Solution
Author(s): Allen Loyd V Jr
May/Jun 2016
Pg. 197-201
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients
Author(s): Sturn Kayla M, Collin Michael
Nov/Dec 2023
Pg. 468-473
Case Study: Personalized Oral Low-dose Naltrexone Titration for Pain Management
Author(s): Rodriguez Franklin, Carvalho Maria, Banov Fabiana
Mar/Apr 2010
Pg. 171-173
Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders
Author(s): Ploesser Jennifer, Weinstock Leonard B, Thomas Erin
Jul/Aug 2018
Pg. 270-278
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report
Author(s): Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don
Mar/Apr 2020
Pg. 94-96
Low-dose Naltrexone Therapy for Psoriasis
Author(s): Weinstock Leonard B, Cottel Jill, Aldridge Lindsey, Egeberg Alexander
Mar/Apr 2012
Pg. 117-124
Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum
Author(s): Zur Eyal
May/Jun 2000
Pg. 215
Saliva Substitute for Dry Mouth/Throat
Author(s): Allen Loyd V Jr
Sep/Oct 2000
Pg. 338
Clinical Management and Review of Sjogren's Syndrome
Author(s): Dyke Shannon
May/Jun 2000
Pg. 176-177
Xerostomia
Author(s): Kuntz Rachael, Allen Michelle, Osburn Jennifer
Jul/Aug 2000
Pg. 255
Dry Mouth Spray
Author(s): Horwitz Robert
May/Jun 2012
Pg. 196-205
Burning Mouth Syndrome: A Discussion of a Complex Pathology
Author(s): Zur Eyal
Jul/Aug 2000
Pg. 257-260
Surviving Cancer - How the Compounding Pharmacist Can Help
Author(s): Maddox Suzan
Nov/Dec 2003
Pg. 460-463
View Sample
Basics of Compounding for Dry-Skin Conditions
Author(s): Allen Loyd V Jr
Sep/Oct 2000
Pg. 381
Pilocarpine HCl 2-mg Troches
Author(s): Allen Loyd V Jr
May/Jun 2000
Pg. 177
Pilocarpine Oral Solution
Author(s): Allen Loyd V Jr
Jan/Feb 2013
Pg. 74-85
View Sample
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
Mar/Apr 2016
Pg. 147
Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray
Author(s): Allen Loyd V Jr
Jan/Feb 2003
Pg. 27-29
Equine Cushing’s Syndrome
Author(s): Vail Jane